In addition to TNBC, ERβ was found to decrease the invasiveness of inflammatory breast cancer (IBC) cells by downregulating GPR141 and the guanine nucleotide exchange factor (GEF)-interacting protein ELMO1 that activate the mediator of IBC metastasis RhoC [65]. The gene discussed is ESR2; the disease is inflammatory breast carcinoma.